Internal Medicine, Critical Care Medicine · Lawrenceville, GA
NPI
1780865527
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
631 Professional Dr, Suite# 350
Lawrenceville, GA, 30046
Phone (770) 995-0630
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
2,836 services
Medicare patients, 2024
695
Average age 75
Drug cost, 2024
$2.8M
6,551 prescriptions
Company payments, 2025
$1,440
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah J Hayat was code 99233 (hospital e&m - subsequent), 684 times for 245 patients. In total Sarah J Hayat billed 2,836 services in 52 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 684 | 245 | $91.93 | $63K |
| 99214 Office E&M - Established | Office | 637 | 317 | $90.98 | $58K |
| 94060 Pulmonary Function Testing | Office | 170 | 158 | $29.69 | $5,048 |
| 94729 Pulmonary Function Testing | Office | 160 | 149 | $40.24 | $6,439 |
| 99232 Hospital E&M - Subsequent | Facility | 149 | 103 | $61.17 | $9,114 |
| 94726 Pulmonary Function Testing | Office | 135 | 126 | $40.95 | $5,528 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 90 | 20 | $57.46 | $5,172 |
| 99222 Hospital E&M - Initial | Facility | 90 | 86 | $102.79 | $9,251 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 79 | 20 | $38.14 | $3,013 |
| 99204 Office E&M - New | Office | 71 | 71 | $108.78 | $7,723 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 59 | 22 | $104.94 | $6,192 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 47 | 22 | $49.82 | $2,342 |
| 99223 Hospital E&M - Initial | Facility | 41 | 40 | $133.69 | $5,481 |
| 95800 Sleep Study | Office | 40 | 33 | $104.68 | $4,187 |
| 95811 Sleep Study | Office | 33 | 33 | $475.61 | $16K |
By year: 2022 $168K for 2,002 services; 2023 $172K for 1,988 services; 2024 $230K for 2,836 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah J Hayat prescribed most often to Medicare patients was Montelukast Sodium, with 1,327 prescriptions and refills. In total Sarah J Hayat wrote 6,551 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,327 | 3,674 | 476 | $11K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 681 | 912 | 143 | $567K |
| Pantoprazole Sodium Generic | 497 | 1,282 | 197 | $4,662 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 487 | 537 | 196 | $14K |
| Breo Ellipta Fluticasone/Vilanterol | 451 | 611 | 134 | $238K |
| Prednisone Generic | 304 | 310 | 219 | $607 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 281 | 374 | 99 | $39K |
| Sucralfate Generic | 181 | 419 | 58 | $3,150 |
| Fluticasone Propionate Generic | 115 | 218 | 53 | $1,191 |
| Arnuity Ellipta Fluticasone Furoate | 114 | 118 | 33 | $27K |
| Nucala Mepolizumab | 111 | 119 | 15 | $439K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 99 | 132 | 40 | $11K |
| Omeprazole Generic | 98 | 272 | 38 | $1,441 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 82 | 110 | 26 | $67K |
| Levocetirizine Dihydrochloride Generic | 80 | 238 | 35 | $1,245 |
Brand drugs: 2,826 claims; generic drugs: 3,725 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah J Hayat $1,440 ($1,440 in general payments such as food, travel and fees) from 11 companies. The largest payer was GlaxoSmithKline, LLC. with $356.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 21 | $356 |
| Insmed, Inc. INSM | 8 | $236 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $179 |
| Merck Sharp & Dohme LLC MRK | 6 | $175 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $153 |
| United Therapeutics Corporation UTHR | 2 | $123 |
| Genzyme Corporation SNY | 4 | $122 |
| Harmony Biosciences LLC HRMY | 1 | $29.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27.66 |
| Amgen Inc. AMGN | 1 | $21.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.